Glassman Wealth Services Amicus Therapeutics, Inc. Transaction History

Glassman Wealth Services

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$6.23 - $11.12 $143 - $255	-23 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$7.89 - $12.48 $552 - $873	-70 Reduced 75.27%	23 $0
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $147 - $186	15 Added 19.23%	93 $1,000
Q2 2021 Aug 04, 2021	SELL	$8.71 - $10.72 $313 - $385	-36 Reduced 31.58%	78 $1,000
Q1 2021 May 05, 2021	BUY	$9.2 - $23.86 $55 - $143	6 Added 5.56%	114 $1,000
Q2 2020 Aug 06, 2020	BUY	$8.86 - $15.69 $469 - $831	53 Added 96.36%	108 $2,000
Q1 2020 May 12, 2020	SELL	$6.63 - $11.16 $13 - $22	-2 Reduced 3.51%	55 $1,000
Q4 2019 Feb 07, 2020	BUY	$7.48 - $10.75 $426 - $612	57 New	57 $1,000

313

311M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.